Chemed Corp at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 17, 2021 / 12:40PM GMT
Michael David Wiederhorn - Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

Good morning. Welcome to Oppenheimer's 31st Annual Healthcare Conference. I'm Michael Wiederhorn. I cover the payers and provider space.

Presenting today is Chemed. We have President and CEO, Kevin McNamara; and Chief Financial Officer, David Williams. We'll do -- we'll be doing this fireside, so I'll just kind of shoot right into the questions here.

Welcome, guys. Hopefully, next year -- like I said, hopefully, next year, we'll be back in person and be breaking bread together.

Questions and Answers:

Michael David Wiederhorn - Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

So first question, can you discuss the factors affecting your hospice census and the time line for that to be fixed in your view?

Kevin J. McNamara - Chemed Corporation - CEO, President & Director

Well, let me start, Mike. Clearly, when we look at what we've been saying for some time externally and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot